Making practical sense of clinical trial data in decreasing cardiovascular risk

Am J Cardiol. 2001 Aug 16;88(4A):16F-20F. doi: 10.1016/s0002-9149(01)01872-0.

Abstract

Clinical studies now affirm what epidemiologic evidence has long suggested-that a broad range of patients can benefit from lipid reduction, including those without overt coronary artery disease and only moderate lipid elevations. Together, these studies suggest that current goals for cholesterol reduction may not be sufficiently stringent to slow the epidemic of heart disease in this country and that aggressive lipid lowering may be just what the doctor should order.

Publication types

  • Review

MeSH terms

  • Animals
  • Cholesterol / blood
  • Coronary Disease / prevention & control*
  • Evidence-Based Medicine
  • Female
  • Humans
  • Hypercholesterolemia / drug therapy*
  • Hypolipidemic Agents / therapeutic use*
  • Male
  • Randomized Controlled Trials as Topic
  • Risk Factors

Substances

  • Hypolipidemic Agents
  • Cholesterol